PepGen Inc. (PEPG)
3.78
-0.15
(-3.82%)
USD |
NASDAQ |
Nov 20, 16:00
3.78
0.00 (0.00%)
After-Hours: 16:15
PepGen Total Assets (Quarterly) : 127.78M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 127.78M |
| June 30, 2026 | 141.40M |
| March 31, 2026 | 156.30M |
| December 31, 2025 | 173.91M |
| September 30, 2025 | 190.06M |
| June 30, 2025 | 102.24M |
| March 31, 2025 | 127.39M |
| December 31, 2024 | 150.88M |
| September 30, 2024 | 170.23M |
| June 30, 2024 | 193.51M |
| March 31, 2024 | 207.00M |
| December 31, 2023 | 143.05M |
| Date | Value |
|---|---|
| September 30, 2023 | 164.27M |
| June 30, 2023 | 182.08M |
| March 31, 2023 | 201.04M |
| December 31, 2022 | 217.44M |
| September 30, 2022 | 208.46M |
| June 30, 2022 | 230.80M |
| March 31, 2022 | 131.88M |
| December 31, 2021 | 143.64M |
| September 30, 2021 | 149.05M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 10.64M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 462.08M |
| IRulya Therapeutics, Inc. | 106.47M |
| Q32 Bio, Inc. | 297.20M |
| Bridgebio Oncology Therapeutics, Inc. | 346.22M |
| Oncolytics Biotech, Inc. | 5.832M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.71M |
| Shareholders Equity (Quarterly) | 103.07M |
| Debt to Equity Ratio | 0.1514 |
| Current Ratio | 8.702 |
| Net Debt Paydown Yield | 0.27% |